Our results demonstrate the necessity of a preceding 5-FU dose to augment PSMA Ab-mediated p50-IMC tumor localization; this phenomenon may also account for the requirement for 5-FU to enable p50-IMC efficacy against B6CaP tumors [8]. Here, FOLH1 is linked to neoplasm.